Evaluation the response to infliximab therapy in patients with ulcerative colitis and crohn's disease

Abstract

Ihab Saeed Ahmed, Alaa Hussein Alwan, Mohanned H Alwan

Aim of study: To evaluate effect of infliximab therapy in Iraqi patients with ulcerative colitis and Crohn`s diseases.
Patients & Methods: A clinical prospective follow up study conducted in Gastroenterology and Hepatology Teaching Hospital-Medical Complex in Baghdad city-Iraq through the period from 1st of July 2013 to 30th of April 2014 on sample of 32 patients with inflammatory bowel disease (19 ulcerative colitis patients and 13 Crohn`s diseases patients). The patients were in active disease and not responding to usual treatment. The patients were administered with an appropriate dose of Infliximab.
Results: The good response to Infliximab was reported in 42.1% of UC patients, partial response in 21.1% of UC patients and no response in 36.8% of UC patients. Mean Mayo score of UC patients before using Infliximab was significantly reduced after using Infliximab (p<0.001). The good response to Infliximab was reported in 61.5% of CD patients, partial response in 15.4% of CD patients and no response in 23.1% of CD patients. Mean CDI score of CD patients before using Infliximab was significantly reduced after using Infliximab (p=0.001). The side effects were minor that restricted to anemia in some cases.
Conclusions: The Infliximab is effective and safe treatment choice for moderate to severe cases of ulcerative colitis and Crohn`s disease.

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3